Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

Generics and biosimilars

Statistics report about generic drugs and biosimilars

Generics and biosimilars

This report presents graphs and tables about the global generic drug industry and market. It also includes a chapter about biosimilars, complex, almost identical copies of biological drugs, which like generic drugs, have the potential for significant drug spending reductions.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Global overview

4
  • Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
  • Basic Statistic Worldwide generic prescription drug sales 2012-2026
  • Basic Statistic Global generic prescription drug revenues as share of prescribed revenue 2012-2026
  • Premium Statistic Patent expiration risks for total worldwide prescription drug revenue 2023-2028

Top companies

4
  • Premium Statistic Revenues of leading global generics manufacturers 2022
  • Premium Statistic Teva Pharmaceutical Industries' generic revenues by region 2016-2023
  • Premium Statistic Novartis revenue 2014-2023 by segment
  • Basic Statistic Pfizer's revenue by segment 2017-2019

U.S. market

6
  • Premium Statistic Brand and generic prescription medication spending in the U.S. 2006-2021
  • Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
  • Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
  • Premium Statistic Unbranded generics revenue top corporations in U.S. 2017-2018
  • Premium Statistic Unbranded generics market share top corporations in U.S. 2017-2018
  • Premium Statistic Top pharma products by prescriptions U.S. 2021

Patent expiration

6
  • Premium Statistic Projected sales at risk due to patent expiry 2014-2023
  • Premium Statistic Top pharma companies by sales loss due to patent loss until 2018
  • Premium Statistic Forecast of new brand and LOE impact in developed pharma markets 2019-2026
  • Premium Statistic Top branded biologic drugs in the U.S. that will go generic by 2028
  • Premium Statistic Time from brand drug launch to generic patent challenges U.S. 1995-2014
  • Basic Statistic Comparison of pre-expiry and generic price for drugs U.S. 2015

Savings

7
  • Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
  • Premium Statistic Total savings of top generic drugs in U.S. 2022
  • Premium Statistic Saving of U.S. costs through generic pharmaceuticals by condition 2022
  • Basic Statistic Savings through generic drug usage in the U.S., by age group 2022
  • Basic Statistic Savings through generic drug usage in the U.S., by payer 2022
  • Basic Statistic Percentage savings through generic drug usage in the U.S. by payer 2022
  • Basic Statistic Savings through generic drug usage in the U.S., by age group share 2022

Biosimilars

7
  • Premium Statistic Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020
  • Premium Statistic Country-wise biosimilar pipelines number in development worldwide 2017
  • Premium Statistic Reduction in U.S. direct spending on originator biologics as of 2018
  • Premium Statistic Share of filgrastim sales attributable to Neupogen or biosimilars US 2015-2018
  • Premium Statistic Share of insuline glargine sales Lantus vs. biosimilar US 2015-2017
  • Premium Statistic Opinion on drug spending reduction due to biosimilars for specialty drugs 2017-2020
  • Basic Statistic Physician office payment for biosimilars in Medicare Part B 2022
Report this content
FURTHER REPORTS

Recommended and recent reports

  • Pharmaceutical industry in Spain
  • Viatris - Form 10-K 2023
  • Pharmaceutical industry in Poland
  • Generics and biosimilars in Italy
  • The U.S. Generic & Biosimilar Medicines Savings Report 2023
  • Pharmaceutical industry in India
  • 2017 Generic Drug Access & Savings in the United States
  • 2022 Trends in Biosimilars Report
  • Generics 2030
  • Canadian pharmaceutical industry
  • Teva
  • Pharmaceutical market in the Philippines
  • Pharmaceutical industry in Brazil
  • Pharmaceutical industry in Romania
  • Pharmaceutical industry in Russia
  • Pharmaceutical industry in Turkey
  • U.S. pharmaceutical industry
  • Pharmaceutical industry in Mexico
  • Pharmaceutical industry in Argentina
  • Il mercato italiano dei farmaci generici - equivalenti 2022

Recommended statistics

You may also be interested in...

Statista report shop

Explore all Statista reports

We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.

Statista report shop Go to reports

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)
Email
support@statista.com

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)
Email
eu.support@statista.com

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Email
latam@statista.com

Mon - Fri, 9am - 6pm (EST)

Menu